Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Department
LocationCancer and Hematology Center
Bone Marrow Transplant / Stem Cell Transplant Program
Lymphoma Program
Texas Medical Center
Specialty
Cancer
Phone: 832-824-4661
Fax: 832-825-7374
Address
6621 FanninSuite 1630.14
Suite 1630.14
Houston, TX 77030
Research Area
Robert A. Krance, MD
Professor, Department of Pediatrics, Section of Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| St. Jude Children's Research Hospital | Fellowship | Hematology-Oncology | 1977 |
| St. Jude Children's Research Hospital | Residency | Pediatrics | 1975 |
| Rocky Mountain College | Residency | Pediatrics | 1972 |
| Rush University Medical Center | Residency | Pediatrics | 1972 |
| Rocky Mountain College | Internship | Pediatrics | 1971 |
| Rush University Medical Center | Internship | Pediatrics | 1971 |
| Loyola University of Chicago | Medical School | Doctor of Medicine | 1970 |
About
Dr. Robert Krance is the Director of the Pediatric Bone Marrow Transplant (BMT)/Stem Cell Transplant Program at Texas Children’s Hospital. The clinical program, one of the most active in the country, treats patients with various hematologic, oncologic, immunologic and genetic disorders.
Dr. Krance coordinates the clinical activities of the cell and gene therapy and the pediatric bone marrow transplant programs.
His clinical interests include bone marrow transplantation and cell and gene therapy.
Board Certifications
American Board of Pediatrics - Pediatric Medicine
American Board of Pediatrics - Hematology/Oncology
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society for Transplantation and Cellular Therapy (ASTCT) | Member |
| American Society of Clinical Oncology (ASCO) | Member |
| American Society of Hematology (ASH) | Member |
Research Statement
Dr. Robert Krance's research interests include: 1) the development of transplantation using alternative donors, 2) transplantation using less than fully HLA matched related donors, and 3) the impact of viral infection post-transplantation.
Current initiatives focus on the development of transplantation using alternative donors and less than fully HLA matched related donors. Investigations are under way into the use of antibodies directed against hematopoietic cells and methods of stem cell purification. In collaboration with other investigators in the Center for Cell and Gene Therapy (CAGT), new cell-based approaches are being conducted hopefully to diminish the impact of viral infection post transplantation.
Selected Publications
Language
English
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.